MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 196 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,052 | -35.3% | 40,901 | -6.5% | 0.01% | -33.3% |
| Q2 2023 | $1,014,055 | -4.7% | 43,747 | -4.5% | 0.01% | -14.3% |
| Q1 2023 | $1,064,166 | -29.2% | 45,810 | -55.7% | 0.01% | +40.0% |
| Q4 2022 | $1,502,076 | +20.5% | 103,520 | +58.4% | 0.01% | -44.4% |
| Q3 2022 | $1,247,000 | +4.2% | 65,345 | -0.8% | 0.02% | +12.5% |
| Q2 2022 | $1,197,000 | -32.1% | 65,866 | -5.8% | 0.02% | -15.8% |
| Q1 2022 | $1,762,000 | -9.9% | 69,921 | -1.3% | 0.02% | -5.0% |
| Q4 2021 | $1,955,000 | – | 70,818 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
| Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
| Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
| Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
| S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
| EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
| SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
| AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
| CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |